Statin use is associated with improved survival in patients undergoing surgery for renal cell carcinoma
Samuel Kaffenberger(Vanderbilt University Medical Center), Peter E. Clark(Levine Cancer Institute), S. Duke Herrell(Vanderbilt University Medical Center), Opal Lin‐Tsai(Vanderbilt University), Daniel A. Barocas(Vanderbilt University Medical Center), Todd M. Morgan(University of Michigan), Sam S. Chang(Vanderbilt University), Joseph A. Smith(Vanderbilt University Medical Center), Kelly Stratton(Oklahoma City University), Michael S. Cookson(University of Oklahoma Health Sciences Center)
Cited by 42
Related Papers
Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
|The Journal of Urology|2007|1.1k
Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes
|The Journal of Urology|2007|845
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
|The Lancet|2018|779
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2023|592
The Treated Natural History of High Risk Superficial Bladder Cancer: 15-year Outcome
|The Journal of Urology|1997|555